The major finding of our study was that plasma omentin levels were significantly lower in patients with OSA, compared to controls, and that neither adiponectin, ghrelin, nor visfatin differs between OSA and control group. This evidence concerns the gene ITLN1 and obstructive sleep apnea syndrome.